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ABSTRACT

THE ROLE OF PHOSDUCIN-LIKE PROTEIN AND THE
CYTOSOLIC CHAPERONIN CCT IN G PROTEIN
BETA GAMMA DIMER ASSEMBLY

Ting Hu
Department of Chemistry and Biochemistry
Doctor of Philosophy

Phosducin-like protein (PhLP), a G protein βγ dimer (Gβγ) binder and G protein
signaling regulator, was suggested to regulate the activity of cytosolic chaperonin CCT
by their high affinity interaction. In the present study, the three-dimensional structure of
PhLP:CCT complex has been solved by cryoelectron microscopy. PhLP was found to
bind only one of the chaperonin rings with both N- and C-terminal domains. It spans the
central folding cavity of CCT and interacts with two opposite sides of the top apical
region, inducing the constraining of the entry of the folding cavity. These findings
support a putative role of PhLP as a co-chaperone similar to prefoldin. Docking studies
with the atomic model of PhLP generated from several known structures of the

homologous phosducin (Pdc) together with the immuno-EM studies have provided more
details of the complex structure and predicted some regions of PhLP and the subunits of
CCT involved in the interaction. Taking advantage of the fact that Pdc is highly
homologous to PhLP but lack of binding to CCT, the regions of PhLP involved in the
interaction with CCT were determined by testing various PhLP/Pdc chimeric proteins in
the CCT binding assay.
In the other part of this dissertation, the physiological role of PhLP in G protein
signaling was investigated. Cellular expression of PhLP was blocked using RNA
interference targeting PhLP. Together with overexpression of PhLP variants and kinetic
studies of Gβγ dimer formation, PhLP was determined to be a positive mediator of G
protein signaling and essential for Gβγ expression and dimer formation. Phosphorylation
of PhLP at serines 18–20 by protein kinase CK2 was required for Gβγ dimer formation,
while a high-affinity interaction of PhLP with CCT appeared unnecessary. Interestingly,
Gβ was found to interact with CCT by co-immunoprecipitation and PhLP overexpression increased the binding of Gβ to CCT. These results suggest that PhLP and CCT
act as co-chaperones in the folding and assembly of the Gβγ dimer by forming a ternary
PhLP-Gβ-CCT complex that is a necessary intermediate in the assembly process.
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CHAPTER 1
Introduction

My research is mainly focused on regulation of the phosducin-like protein (PhLP)
and cytosolic chaperone CCT on Gβγ signaling. This introduction will have three parts: G
protein signaling, PhLP function in G protein signaling and CCT-mediated protein
folding.
G protein Signaling
Cellular responses to the external signals from an ever-changing environment are
essential for the survival and evolution of an organism. Membrane-spanning receptormediated activation of heterotrimeric G protein is a widely used signaling strategy that
cells employ to respond to diverse stimuli. G protein signaling has received considerable
attention and intense research effort over the past twenty years. As more novel pathways
that use G proteins have been discovered, recognition of the diversity of regulatory
mechanisms of G protein signaling is also increasing. It is now known that G protein
signaling is involved in a wide variety of important biological processes including vision,
olfaction, chemotaxis, immune responses and many other vital physiological events.
Aberrations in the functioning of G protein signaling can contribute to pathogenesis of
many diseases, including asthma, inflammation, obesity, cancer, cardiovascular,
metabolic, gastrointestinal and central nervous system diseases.
G proteins are so named because the Gα subunit binds the guanonine nucleotides
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GTP/GDP and functions as a GTPase. They are signal transducers and amplifiers that
provide a link between the G protein-coupled receptor (GPCR) and a number of effectors
within the cell. Since the first GPCR, the β-adrenergic receptor, was purified by Shorr et
al. in 1981 (Shorr et al., 1981), hundreds of GPCRs have been cloned and this list
continues to grow. In vertebrates, this family is predicated to have nearly 1000 members
(>2% of the genome), half of which code for odorant and pheromone receptors, and the
Caenorhabditis elegans genome encodes ~1100 GPCRs (5% of the genome) (BenShlomo et al., 2003). Despite the large number of GPCRs, evidence has also indicated
that many GRCRs function as dimers (or higher order oligomers) with themselves or
other GPCRs to transduce the signal (Breitwieser, 2004; Filizola and Weinstein, 2005).
The important biological role of GPCRs has been explored and applied extensively for
pathogenesis study and drug design. These targets will continue to be keys in the search
for effective therapeutics. More than 50% of currently marketed drugs target GPCRs,
with sales of $30~60 billion annually (http://www.sentigen.com/applications/drug.php),
although only 10% of GPCRs are known drug targets (Vassilatis et al., 2003). As new
functions for GPCRs are discovered, the number of drugs that target GPCRs can only be
expected to increase.
Although the GPCR superfamily compose a large number of receptors, responds
to numerous stimuli and activates various intracellular signaling pathways, GPCRs share
common structural features. All GPCRs have an extracellular N terminus, a cytoplasmic
C terminus and seven transmembrane α-helices which are connected alternately by three
extracellular loops (e1-e3), and three intracellular loops (i1-i3) (Gether, 2000; Ji et al.,
1998; Palczewski et al., 2000). The G-protein is a heterotrimer consisting of three
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subunits α, β, and γ. The N-terminus of the Gα and the C-terminus of the Gγ subunits are
lipid modified for membrane anchoring of these proteins. Gα subunits are generally
myristoylated and palmitoylated at their N termini. The Gγ-subunit when dimerized with
the Gβ subunit is isoprenylated at the C-terminus (Resh, 1996; Wedegaertner, 1998;
Wedegaertner et al., 1995). The G protein is thus anchored to the inner leaflet of the
plasma membrane by these lipid modifications. When ligands (neurotransmitters,
hormones and lipids) bind the extracellular domain of their cognate GPCRs, the receptors
undergo conformational changes, creating a high affinity binding site for the G protein.
This interaction catalyzes the exchange of GDP for GTP on the Gα subunit, which leads
to dissociation of Gα·GTP from the Gβγ complex. The dissociated Gα-GTP and Gβγ
subunits proceed to interact directly with a number of downstream effectors to continue
the signaling cascade that in the end mediates the physiological response to the stimulus.
Gα subunits contain two domains: a GTPase domain involved in the binding and
hydrolyzing of GTP and a helical domain unique to the Gα subunits that buries the GTP
within the core of the protein. The helical domain is divergent among G protein families
and may play a role in directing the specificity of coupling to receptors and effectors.
Within the GTPase domain there are three switch regions (switches I, II, and III). These
regions undergo conformational changes upon GTP binding that result in a loss of
contacts with Gβγ, which causes release of Gα-GTP from Gβγ and unmasks the binding
sites for effectors (Lambright et al., 1994; Noel et al., 1993). Structurally, Gβ is member
of WD40 repeat protein super-family. WD40 repeat proteins generally constitute 4-16
repeating motifs. Each motif is about 40 amino acids long, terminating with a conserved
Trp-Asp (W-D). This family includes many other eukaryotic proteins like yeast STE4,
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MSI1, CDC4, CDC20, MAK11, PRP4, PWP1 and TUP1, slime-mold AAC3 and
coronin, and Drosophila Groucho protein (Smith et al., 1999; van Nocker and Ludwig,
2003). WD40 proteins are speculated to have a similar circularized β-propeller structure.
Gβ has seven tandem WD40 repeats. It has a propeller-like structure with 7 blades and
each blade is composed of a four-stranded anti-parallel β-sheet. Each WD40 repeat forms
the first three strands of one blade and the last strand in the next blade. Interactions
between blade 1 and 7 maintain the closed ring structure of the propeller. The Gγ subunit
associates tightly with Gβ subunit through an N-terminal coiled-coil and then all along
the side of Gβ subunit propeller opposite Gα, making extensive contacts (Gaudet et al.,
1996; Wall et al., 1995).

Figure 1-1 Structural representation of the
G protein interaction with a GPCR and the
membrane lipid bilayer, using rhodopsin
and transducin as the prototype for GPCR
family and G protein respectively. Seven
TMs are color-labeled progressionally
from red (the extracellular N-terminus) to
blue (the C-terminus). TM1–TM7 run
counterclockwise when top-viewed. The
membrane bilayer is green. The structures
of the intracellular and extracellular loops
are not known and are hand drawn to show
helix connectivity. The Gα subunit is
medium blue, the Gβ subunit is light green,
and the Gγ is yellow. The bound guanine
nucleotide (GDP) is red. The palmitylated
C terminus of rhodopsin, myristoylated
and/or palmitoylated N terminus of Gα,
and farnesylated C terminus of Gγ are
shown interacting with the membrane. This
picture is taken from Hamm, 2001.

Each G protein subunit has several isoforms: 23 alpha, 6 beta, and 12 gamma gene
4

products (Downes and Gautam, 1999). Based on the similarity of their Gα amino acid
sequences, G proteins are divided into four main classes: Gs, Gi/o, Gq/11, and G12/13.
In the Gs pathway, Gs couples many GPCRs and their activated Gα subunits bind
and activate adenylyl cyclase, the enzyme catalyzing the synthesis of cAMP. Increasing
concentration of intracellular cAMP directly mediates the gating of cyclic nucleotide –
gated ion channels and activates protein kinase A (PKA), which in turn phosphorylates
numerous proteins (Wettschureck and Offermanns, 2005). This pathway can be activated
constitutively by cholera toxin which ADP-ribosylates Gα of this family and inhibits the
GTPase activity of Gα.
In the Gi pathway, its Gα subunit (Gi1, Gi2, Gi3) has been reported to inhibit many
types of adenylyl cyclase. The Gi family members are inhibited by pertussis toxin, which
ADP-ribosylates the Giα subunit at its C-terminus, thereby uncoupling Gi from its
receptors.
Gq/11 family members couple receptors to PLC-β and can be activated by calciummobilizing hormones. Activated PLC-β hydrolyzes phosphatidylinositol 4,5 bisphosphate
(PIP2) to produce intracellular messengers inositol 1,4,5 trisphosphate (IP3) and
diacylglycerol (DAG). Both of these molecules are important second messengers. IP3
activates IP3 receptors (IP3R) in the endoplasmic reticulum (ER) and results in an
increased intracellular Ca2+ concentration. DAG remains associated with the membrane,
recruits protein kinase C (PKC) to the membrane and activates it (Neves et al., 2002).
Direct effectors and receptors for G12/13 remain largely unsolved. The two bestcharacterized subsets of G12 effectors are a class of Rho-specific guanine nucleotide
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exchange factors as well as members of the cadherin superfamily of cell surface adhesion
proteins (Meigs et al., 2005). Gα12 has been discovered to directly interact with protein
phosphatase 2A (PP2A) (Zhu et al., 2004), a GTPase-activating protein for Ras, RasGAP,
and Bruton’s tyrosine kinase (Btk). Gα12 is also speculated to activate phopholipase D, cSrc and PKC by as yet unidentified mechanisms (Neves et al., 2002). G12/13 signaling
appears to involve the stimulation of Na+/H+ exchangers (Dhanasekaran et al., 1994; Lin
et al., 1996) and Rho GTPase (Buhl et al., 1995).

Figure 1-2 Families of heterotrimeric G proteins and their typical patterns of receptor/G protein coupling.
This schematic representation shows the typical pathways by which the four main classes (Gs, Gi/o, Gq/11,
and G12/13) of G proteins regulate the cellular response after ligand-dependent receptor activation. This
figure was taken from a recent review paper (Wettschureck and Offermanns, 2005).

Gβγ is also reported to interact with and activate several effectors. Because of the
high expression level of Gi/o, their activations are believed to be a major mechanism for
Gβγ signaling (Wettschureck and Offermanns, 2005). Gβγ has been shown to directly
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regulate PLC-β2 and 3 (Murthy et al., 1996), GRK2 (Lodowski et al., 2003), inwardly
rectifying K+ (GIRK) channels (Clapham and Neer, 1997; Dascal, 1997), adenylyl
cyclase (AC) (Cooper, 2003; Taussig et al., 1993), phosphoinositide 3-kinase (PI3
kinase) (Stephens et al., 1994), components of the MAPK cascade and Ca2+ channels
(Delmas et al., 1998). The list of Gβγ effectors is still expanding.
G protein signaling is strictly regulated by multiple mechanisms at different stages
of the signaling cascade. Turning signal on and off rapidly ensures timely cellular
responses and prevents cells from excessive responses to extracellular stimuli. Reducing
receptor number and uncoupling from G proteins are important means to attenuate
signaling. Generally, desensitization and internalization of GPCRs takes a few steps.
Upon persistent ligand binding, G protein receptor kinases (GRK) or second-messengerdependent kinases such as PKA and PKC phosphorylate serine or threonine residues in
the third internal loop or carboxyl tail of the agonist-bound GPCR. GRK phosphorylation
promotes the binding of β-arrestins to the GPCR, which uncouples the receptor from its
G proteins. The uncoupled GPCR aggregates on the cell surface in a clathrin-coated pit
and is subsequently endocytosed (Ferguson, 2001; Zhang et al., 1996). Dynamin forms
the necks of clathrin-coated pits and catalyses the fission of clathrin-coated pits from the
plasma membrane (Bünemann and Hosey, 1999). GPCRs in the endocytotic vesicles can
either be targeted to lysosomes for degradation or recycled back to the membrane after
dephosphorylation release of arrestin. All GPCRs don’t undergo this arrestin- and
clathrin-dependent pathway, but this is currently the most common known pathway for
GPCR desensitization and internalization.
Hydrolysis of GTP by the Gα subunit also terminates the signaling. Gα has
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intrinsic GTPase activity that determines the lifetime of the activated G protein and the
duration of effector activation. Once GTP is hydrolyzed to GDP, inactivated Gα
reassociates with Gβγ, reforming the heterotrimer for another round of activation. Like
the intrinsic GDP release rates, intrinsic GTP hydrolysis activity varies among Gαsubunits. Some regulatory proteins interact with Gα and mediate its GTP hydrolysis
activity, including guanine nucleotide exchange factors (GEFs) that accelerate the release
of bound GDP, guanine nucleotide dissociation inhibitors (GDIs) that counteract this
process and GTPase-activating proteins (GAPs) that accelerate the rate of intrinsic
GTPase activity (Gudermann et al., 1997; Siderovski and Willard, 2005). A few effectors
have been shown to accelerate the rate of GTP hydrolysis, including cGMP
phosphodieterase (Arshavsky and Bownds, 1992), p115RhoGEF (Kozasa et al., 1998)
and PLC-β (Berstein et al., 1992)  Regulators of G-protein signaling (RGS) family have
been shown to accelerate the rate of GTP hydrolysis, thereby reducing the duration and
amplitude of the signaling (Riddle et al., 2005; Ross and Wilkie, 2000). The Gβγ subunits
also have binding partners that have been reported to regulate G protein signaling.
Phosducin (Pdc) and phosducin-like protein bind Gβγ with high affinity, preventing their
interaction with Gα and effectors. The goal of the research reported here is to better
understand of the role of PhLP in the regulation of Gβγ signaling. This work will have
practical benefits to help in the design of drugs that control cellular expression of Gβγ.
Phosducin and Phosducin-like protein
Phosducin-like protein (PhLP) was first discovered as the product of an ethanolinduced gene in cultured neuronal cells in 1993. It has 41% identity and 65% homology
to phosducin (Pdc) in its amino acid sequence (Miles et al., 1993). Pdc was discovered
8

earlier and studied more extensively in the past decade. It is a 28 kDa cytosolic protein,
mainly expressed in the retina and pineal gland, but very low levels are found in many
other mammalian tissues. It binds Gβγ and is believed to be a Gβγ regulator (Bauer et al.,
1992; Lee et al., 1992). It down-regulates G protein signaling by sequestering Gβγ in the
cytosol, thus blocking the association of Gβγ with Gα subunits, effectors and membranes.
PKA and CaMKII can phosphorylate Pdc, and the phophorylation status regulates its
interaction with Gβγ (Thulin et al., 2001). The X-ray crystal structure of Gtβγ-Pdc
complex shows that Pdc has an N-terminal helical domain and a C-terminal thoredoxinlike domain (Gaudet et al., 1996). Both domains are involved in the interaction with Gβ.
The N-terminal helical domain of Pdc binds extensively to the loops of Gβ that provide
the interaction with Gα, while the C-terminal domain of Pdc binds to the region of Gβγ
that associates with the membrane surface (Gaudet et al., 1996).

Figure 1-3 Overall structure of the phosducin/Gtβγ complex. Gtβ is gold, and Gtγ is silver. The N- and Cterminal domains of phosducin are shown in purple and blue respectively. The poorly defined segment
from 37 to 66 in phosducin is shown in green. A and B show top and side views of the Gβ propeller in a
ribbon representation. This structure was from Gaudet et al, 1999.
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Blaauw et al. analyzed 33 Pdc sequences from mammals, invertebrates, plants and
unicellular eukaryotes (Blaauw et al., 2003). Their phylogenetic study concluded that the
Pdc family consists of three subgroups, named Pdc-I, Pdc-II and Pdc-III as shown in
Figure 4. Both mammalian Pdc and PhLP fall into the Pdc-I subgroup. Like Pdc, PhLP
also binds Gβ (Thibault et al., 1997). PhLP is constitutively phosphorylated by protein
kinase CK2 in mammalian cell lines (Humrich et al., 2003). Unlike Pdc, the interaction of
PhLP with Gβ is not effected by its phosphorylation. Over-expression of PhLP blocked G
protein signaling through the angiotensin type 1 receptor (McLaughlin et al., 2002b).
Since PhLP is expressed more widely than Pdc, it has been described as a ubiquitous
negative regulator of Gβγ function.

Figure 1-4. The phosducin family
consists
of
three
defined
subgroups. This phylogenetic tree
was taken from Blaauw et al.,
2003. It was generated from 33
phosducin homolog sequences
from different organisms. The
numbers are bootstrap values
which indicate the likelihood that
a given branch would be
unaffected if additional data, with
the same distribution, became
available. Values approaching
100 indicate greater confidence in
the branch point.

However, several observations suggest that PhLP is not a negative regulator of
Gβγ signaling. In the chestnut blight fungus C. parasitica, disruption of the BDM-1
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gene, the only phosducin-I group gene in this organism, resulted in a phenotype
indistinguishable from disruption of the Gβ subunit gene (Kasahara et al., 2000).
Moreover, disruption of phlp1 gene in Dictyostelium also had a Gβ-null phenotype and G
protein signaling in these cells was blocked. In addition, Gβ and Gγ lost their membraneassociation and were found in the cytosol in the phlp1-null cells (Blaauw et al., 2003).
Furthermore, knockdown of PhLP expression in mouse brain prolonged the duration of
opiate desensitization (Garzon et al., 2002). Together, these findings provide evidence
that rather than sequestering Gβγ and inhibiting G protein signaling, PhLP is somehow
required for Gβγ function. Clues regarding other functions of PhLP have come from the
observation that PhLP binds the chaperonin containing tailless complex polypeptide 1
(CCT) (McLaughlin et al., 2002b). CCT is an essential chaperone in the folding of actin,
tubulin and a number of other proteins including proteins with WD40 repeats similar to
Gβ (Valpuesta et al., 2002). Thus, it is possible that PhLP is involved in protein folding
processes.
Cytosolic chaperonin-containing t-complex (CCT)
Proteins will only function properly when they fold into their three-dimensional
structures. Most newly synthesized proteins and partially denatured proteins resulting
from various cell stresses depend a great deal on the assistance of other proteins called
“chaperones” to acquire their native structure. Chaperones were originally identified in
the mid-1980s from studies of protein folding and assembly in plant chloroplasts.
Molecular chaperones are defined as “a group of unrelated proteins that mediate the
correct folding, assembly, reparation, translocation across membranes and degradation of
other proteins and simultaneously are not their functional components.” (Frydman, 2001)
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Chaperones can prevent newly synthesized proteins from aggregation in the crowded
cellular environment by recognizing and shielding hydrophobic surfaces. They can also
unfold incorrectly folded proteins, allowing them to recover. The folding is often an
ATP-dependent process and involves repetitive binding and release of the chaperones and
of the substrate protein.
There are two major ATP-dependent chaperones for protein folding in the cytosol
of eukaryotic and prokaryotic cells: the Hsp70s and Hsp60s (also called the cylindrical
chaperonin complexes). The name Hsp70 is derived from the induced expression of this
70 kDa protein by heat-shock treatment. This chaperone family constitutes a highly
conserved group of molecular chaperones, including DnaK from Escherichia coli, the Ssa
and Ssb proteins from yeast, and BiP from the mammalian endoplasmic reticulum (Cyr
and Douglas, 1994). They play an important role in polypeptide folding, translocation,
activation and degradation. In Hsp70-assisted folding reactions, Hsp70 undergoes
repeated cycles of binding/release of substrate proteins and hydrolysis of ATP (Fink,
1999). To fulfill its role, Hsp70 often needs one or more co-chaperones, such as Hsp40,
to enhance its ATPase activity and Hip to stablize ADP binding.
Chaperonins are catagorized into two groups based on their origin. Group I
chaperonins exist in eubacterial cells, such as GroEL of E. coli and Hsp60 in
mitochondria and chloroplasts. Group II Chaperonins are the thermosome in Archaea and
CCT (also called TRiC or c-cpn) in Eukarya. The two groups share similar structures and
conserved folding mechanisms while they still have substantial difference. Group I
chaperonins are composed of two superimposed rings made of 7 identical subunits in
each ring. They require a co-chaperone to function, GroES for GroEL and Hsp10 for
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Hsp60. Co-chaperones GroES and Hsp10 serve as a lid for the folding cage where
polypeptide substrates are sequestered during folding.
Group II chaperonins have similar structure as group I members. However, they
do not need a co-chaperone to act as a lid for the folding cavity. CCT also has a toroidal
structure composed of two superimposed rings. Each ring is constituted of eight different
but homologous subunits, enclosing a cavity in which folding takes place. Each subunit
has three domains: apical, intermediate, and equatorial. The apical domain is involved in
substrate binding and undergoes large conformational changes during the folding cycle
(Frydman et al., 1992; Gao et al., 1992). Compared with group I chaperonins, there is an
extra protrusion region located on the tip of the apical domain that enables CCT to close
up its substrate-folding cavity upon ATP binding in the absence of a co-chaperone. The
eight heterologous subunits (CCT α, β, γ, δ, ε, ζ, η, θ) of CCT are arranged with a certain
order and orientation. CCT binds its substrate through specific subunits. It uses two
different sets of subunits to interact with actin and tubulin (Llorca et al., 1999). As with
group I chaperonins, CCT also folds and releases unfolded polypeptides in an ATPdependent manner.
CCT assists the folding of many cellular proteins. Approximately 10 –15% of
newly synthesized proteins were found to transit through CCT (Thulasiraman et al.,
1999). Some of these are proven CCT substrates, including actin, tubulin, Gα, cyclin E
and some members of the WD 40 protein family such as cdc20 and VHL (Feldman et al.,
2003). PhLP interacts with CCT in its native form and over-expression of PhLP has been
reported to competitively inhibit folding of actin by CCT (McLaughlin et al., 2002b).
Prefoldin is a co-chaperonin for CCT that binds to the nascent chain of actin
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cotranslationally and passes it on to CCT for further folding of actin. The cryo-EM
structure of the CCT-prefoldin complex shows that prefoldin binds to the apical domain
of each of the CCT rings in a unique conformation through two specific CCT subunits
that are placed in a 1,4 arrangement (Martin-Benito et al., 2002).

Figure 1-5. Structures of group I and group II chaperonin systems and the schematic representation of
function cycling model. (a) Structures of GroEL and GroES in space-filling representation. (Left)
Unliganded GroEL. (Center) GroEL-GroES-(ADP)7. The apical, equatorial and intermediate domains
are orange, cyan, and magenta, respectively. GroES protomer in the GroEL-GroES complex is in dark
green. (Right) An interior view of GroEL-GroES-(ADP)7. The surface of this complex is colored
according to relative hydrophobicity of side chains. (b) Schematic model of a GroEL–GroES mediated
folding reaction cycle. GroES is in red and GroEL is in blue. (c) Structures of group II chaperonins.
(Left) nucleotide-free thermosome. (Center) Closed conformation of the thermosome. Color code is
same as in (a), only dark green is for the helical protrusion. (Right) Cryo-EM strucure of actin-TRiC
complex from an interior view. TriC is in yellow, and its substrate in red. This picture was taken from a
recent review paper (Frydman, 2001).
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To gain insight into the role of PhLP in CCT binding, the structure of the PhLPCCT complex was investigated by cryo-EM and site-directed mutagenesis methods. The
findings of these studies are reported in Chapter 2. The structure of the PhLP-CCT
complex suggested that PhLP might act as a co-chaperone in Gβγ folding and assembly.
This possibility was examined in the studies reported in Chapter 3.
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CHAPTER 2

Structure of the complex between the cytosolic chaperonin CCT
and phosducin-like protein

Summary

The three-dimensional structure of the complex formed between the cytosolic
chaperonin CCT (chaperonin containing TCP-1) and phosducin (Pdc)-like protein
(PhLP), a regulator of CCT activity, has been solved by cryoelectron microscopy.
Binding of PhLP to CCT occurs through only one of the chaperonin rings, and the protein
does not occupy the central folding cavity but rather sits above it through interactions
with two regions on opposite sides of the ring. This causes the apical domains of the CCT
subunits to close in, thus excluding access to the folding cavity. The atomic model of
PhLP generated from several atomic structures of the homologous Pdc fits very well with
the mass of the complex attributable to PhLP and predicts the involvement of several
sequences of PhLP in CCT binding. Binding experiments performed with PhLP/Pdc
chimeric proteins, taking advantage of the fact that Pdc does not interact with CCT,
confirm that both the N- and C-terminal domains of PhLP are involved in CCT binding
and that several regions suggested by the docking experiment are indeed critical in the
interaction with the cytosolic chaperonin.
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Introduction
Molecular chaperones are a large class of proteins that assist other proteins in
attaining their active conformation. Among them, chaperonins are a ubiquitous family of
chaperones that have a common toroidal structure formed by the oligomerization of 60kDa proteins. The toroid is made of two rings placed back-to-back with each ring
enclosing a cavity where folding occurs (Ellis, 1996). Chaperonins have been classically
divided into two groups depending on whether they are found in eubacteria and in the
endosymbiotic organelles (group I) (Ellis and Hartl, 1999) or in archaea and the cytosol
of eukarya (group II) (Gutsche et al., 1999). The monomers of every chaperonin known
share a very similar three-domain structure (Braig et al., 1994; Ditzel et al., 1998): an
equatorial domain that contains the nucleotide binding site and most of the interaction
sites between the subunits of the same ring and of the opposite ring; an apical domain
where the substrate binding site is located; and an intermediate domain that transmits to
the apical domain the signals generated in the equatorial domain upon nucleotide binding.
Chaperonins act on unfolded substrates by a general mechanism that involves the
recognition of the unfolded polypeptide by hydrophobic residues at the entrance of the
chaperonin cavity, followed by folding of the polypeptide upon closure of the cavity
induced by the binding of ATP and a cochaperonin (Gomez-Puertas et al., 2004).
A more specific mechanism seems to operate for the group II eukaryotic cytosolic
chaperonin CCT (chaperonin containing TCP-1), whose toroidal structure is made up of
two rings composed of eight different but homologous proteins (Willison, 1999). The
work carried out with the major CCT substrates, actin and tubulin, has shown that the
recognition mechanism operates through defined CCT subunits and specific domains of
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the substrates, which have already acquired a large degree of native-like conformation
before interacting with CCT. The conformational changes undergone by CCT upon
nucleotide binding would be used to actively fold the two cytoskeletal proteins (GomezPuertas et al., 2004) or to generate a structure apt to form a stable complex with other
proteins (Valpuesta et al., 2004).
In contrast, a novel role for CCT other than folding or complex formation seems to
be behind its interaction with PhLP. PhLP and its homologue Pdc are involved in the
regulation of cell signaling through their interaction with the G protein subunit complex
(Gβγ). Binding of PhLP or Pdc prevents Gβγ from interacting with the Gα subunit or
downstream effectors (Bauer et al., 1992; Gaudet et al., 1996; Hawes et al., 1994; Lee et
al., 1992; McLaughlin et al., 2002a). Unlike protein folding substrates, PhLP has been
shown to interact with CCT in its native form and to inhibit the chaperonin actin folding
activity (McLaughlin et al., 2002b), suggesting that PhLP may be a regulator of CCT
activity or conversely that CCT could control the availability of PhLP during G protein
signaling (McLaughlin et al., 2002b). To gain further insight into the interaction between
CCT and PhLP, we have carried out electron microscopy and biochemical analysis of the
CCT:PhLP complex. The three-dimensional reconstruction of CCT:PhLP obtained by
cryoelectron microscopy together with a docking analysis carried out with an atomic
model of PhLP and with CCT binding experiments performed with various PhLP mutants
has led to the determination of the regions of PhLP and the subunits of CCT involved in
the formation of the CCT:PhLP complex, and to a hypothesis of the role of the CCT:PhLP
interaction.
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Materials and Methods
Protein Preparation. CCT was purified from soluble extracts of bovine testis as
described previously (Martin-Benito et al., 2002). Gβ1γ1 was purified from bovine retina
and recombinant rat PhLP, and the PhLP/Pdc chimeric proteins were expressed and
purified from Escherichia coli as described (Savage et al., 2000). The CCT:PhLP
complexes were formed by incubating CCT and PhLP in a 1:10 molar ratio for 30 min at
25°C. In the case of the CCT:PhLP:antibody immunocomplexes, preformed CCT:PhLP
complexes

were

incubated

with

anti-CCTd8g

monoclonal

antibody

(5:1

antibody:complex molar ratio) during 15 min at 25°C.
Generation of PhLP/Pdc Chimeras. The cDNA for wild-type rat PhLP and Pdc with a
3' c-myc epitope tag were previously constructed in the pET15b vector (McLaughlin et
al., 2002b). The PhLP/Pdc chimeras were made by PCR amplification of two PhLP
cDNA fragments from this vector. The fragments were divided at an endonuclease
restriction site within the Pdc sequence to be inserted or the PhLP sequence near the
replacement point. If the restriction site was within the Pdc insert, fragments were
amplified with primers complimentary to the sequence of PhLP at the replacement point
with overhangs containing the Pdc sequence including the restriction site. If there was no
restriction site within the Pdc insert, then a primer containing complementary nucleotides
of PhLP next to the replacement point, the entire Pdc sequence to be inserted, and the
additional PhLP sequence up to the restriction site was used. The other primer was
complementary to PhLP sequence including the restriction site. Each fragment was then
amplified by pairing these primers with either the T7 forward or reverse primers from
pET15b flanking the PhLP cDNA. The fragments were cut at the restriction site, gel-

19

purified, and ligated. The full-length chimeras were then PCR-amplified by using the T7
forward and reverse primers and inserted into the pET15b vector by using the NcoRI and
BamHI restriction sites. For the P193R chimera, the single amino acid substitution was
made by using the QuikChange protocol (Stratagene). All constructs were confirmed by
DNA sequence analysis.
Binding of PhLP/Pdc Chimeras to CCT. Binding of the PhLP/Pdc chimeras to CCT
was measured by coimmunoprecipitation and immunoblotting. Purified PhLP/Pdc
chimeric proteins (250 nM) were added to 10% rabbit reticulocyte lysate in PBS with 0.5
mM PMSF and 0.5% Igepal CA-630 detergent in a 100-µl total volume and incubated for
15 min at 4°C. PhLP/Pdc complexes were immunoprecipitated by using an antibody to
the C-terminal c-myc tag fused to each chimera and immunoblotted with an antibody to
CCTα or Gβγ as described (McLaughlin et al., 2002b). Intensities of the CCTα bands
from the PhLP/Pdc chimera were expressed as a percentage of the CCTα band intensity
from the wild-type PhLP immunoprecipitates.
Electron Microscopy. For cryoelectron microscopy, 5-µl aliquots of a solution
containing CCT:PhLP complexes were applied to glow-discharged holey carbon grids for
1 min, blotted for 5 sec, and frozen rapidly in liquid ethane at –180°C. Images were
recorded at 20° tilt under minimum dose conditions in a FEI G2 FEG electron microscope
equipped with a Gatan cold stage operated at 200 kV and recorded on Kodak SO-163 film
at x62,000 nominal magnification and between 1.5 and 2.5 µm underfocus. For electron
microscopy of negatively stained samples, 5-µl aliquots were applied to glow-discharged
carbon grids for 1 min and then stained for 1 min with 2% uranyl acetate. Images were
recorded at 0° tilt in a JEOL 1200EX-II electron microscope operated at 100 kV and
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recorded at x 60,000 nominal magnification.
Image

Processing,

Two-Dimensional

Averaging,

and

Three-Dimensional

Reconstruction. Micrographs were digitized in a Zeiss SCAI scanner with a sampling
window corresponding to 3.5 Å per pixel for negatively stained samples and 3.2 Å per
pixel for vitrified samples. For two-dimensional classification and averaging, top and side
views of CCT particles were selected, aligned by using a free-pattern algorithm, and
classified by using self-organizing maps as described (Martin-Benito et al., 2002) to
separate the PhLP-bound CCT particles from those free of PhLP.
The three-dimensional reconstruction of the CCT:PhLP complex was generated
from randomly oriented particles whose orientation was determined by using the angular
refinement algorithms provided by SPIDER (Frank, 1996). The volumes were generated
by using the back-projection method (Guex and Peitsch, 1997). No symmetrization was
applied to any of the volumes obtained during the iterative procedure. The final resolution
was estimated with the 0.5 criterion for the Fourier shell correlation coefficient between
two independent reconstructions by using BSOFT (Heymann, 2001).Visualization of the
volumes was carried out by using AMIRA (http://amira.zib.de).
Modeling of PhLP and Docking of the CCT:PhLP Complex. The atomic model of
PhLP was generated by homology modeling techniques using the sequences and atomic
structures of four Pdc proteins (PDB ID codes 2TRC, 1AOR, 1B9Y, and 1B9X) with the
DALI comparison algorithm (Holm and Sander, 1993) at the SWISS-MODEL server
facilities

(Guex

and

Peitsch,

1997)

(http://swissmodel.expasy.org//SWISS-

MODEL.html). The atomic model of PhLP was then fitted manually into the threedimensional reconstruction of the CCT:PhLP complex by using O (Jones et al., 1991 ).
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Results and Discussion
The Formation of the CCT:PhLP Complex.
To confirm the reported interaction of PhLP with CCT and to visualize the
CCT:PhLP complexes, purified CCT was incubated in the absence or presence of a 10
molar excess of purified PhLP, and the samples were stained as described in Materials
and Methods. Two typical views were observed under the electron microscope: the most
common top view revealing the octameric nature of the CCT rings, and the less frequent
side view showing the two-ring structure of the chaperonin. The latter view turned out to
be the most informative in detecting the absence (Fig. 2-1A) or the presence of PhLP
bound to the chaperonin oligomer (Fig. 2-1B), which seems to occur outside the folding
cavity. PhLP protrudes from the apical region of the chaperonin in a manner similar to the
interaction between CCT and its cochaperone prefoldin (PFD) (Martin-Benito et al.,
2002). However, unlike what happens with PFD, the side views of the CCT:PhLP
complex indicate that the interaction between PhLP and CCT occurs with only one of the
chaperonin rings, regardless of the amount of PhLP added to the CCT solution,
confirming the 1:1 stoichiometry for the CCT:PhLP complex described previously
(McLaughlin et al., 2002b).
CCT Subunits Involved in PhLP Binding.
The side view of the CCT:PhLP complex depicted in Fig. 2-1 B also suggests the
interaction of PhLP with regions on opposite sides of the CCT cavity. This orientation is
confirmed by the average top view image of the same complex (Fig. 2-1 C), which shows
that an asymmetric mass traverses the chaperonin cavity and interacts with two CCT
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Figure 2-1. Two-dimensional average images of negatively stained CCT:PhLP complex. (A) Average
image of side views obtained from 243 CCT particles of apo-CCT. (B) Average image obtained from 286
side views of CCT:PhLP complexes. (C) Average image obtained from 4,225 top views of CCT:PhLP
complexes. (D and E) Average images of the two types of top views of CCT:PhLP:8g (anti-CCTδ)
immunocomplexes (average of 324 and 626 particles). The subunit labeled by the antibody is marked with
"δ" (Scale bar, 100 Å.) A schematic model of the each mode of PhLP binding, with the topology of the
CCT subunits according to ref. (Liou and Willison, 1997), accompanies each average image.

subunits on one side of the cavity and three CCT subunits in the other side. This
interaction is geometry-dependent, similar to what has already been described for actin
(Llorca et al., 1999) and tubulin (Llorca et al., 2000). To determine whether the
interaction is also subunit-specific we made use of a monoclonal antibody reacting
against the CCTδ subunit (8g) (Llorca et al., 1999). Aliquots of the immunocomplexes
were negatively stained (to contrast only one of the CCT rings), and 950 top views were
processed. After the classification procedures, two main populations were obtained with
PhLP present in the CCT cavity whose average images are represented in Fig. 2-1D and
E, respectively. Both images reproduce a similar mass crossing the CCT cavity. The
specificity of the monoclonal antibody and the known topology of the CCT ring (Liou
and Willison, 1997) allowed determination of the CCT subunits involved in PhLP
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binding. The average image shown in Fig. 2-1D represents 65% of the CCT:PhLP
complexes and points to an interaction of PhLP with CCTγ/θ on one side of the CCT
cavity and CCTα/ε/ζ on the other side. In the average image representing the remaining
35% of the CCT:PhLP complexes (Fig. 2-1E), PhLP seems to interact with CCTδ/η on
one side of the cavity and CCTζ/β/γ on the other side. The structural basis for these two
different modes of interaction and their physiologically relevance remains to be
determined. Nevertheless, in either structure PhLP binding occludes the CCT cavity,
possibly explaining why PhLP competes with other substrates for their interaction with
CCT and therefore regulates the chaperonin folding activity (McLaughlin et al., 2002b).
Three-Dimensional Structure of the CCT:PhLP Complex.
To further characterize the interaction between PhLP and the cytosolic chaperonin,
a three-dimensional reconstruction of the CCT:PhLP complex was carried out by
cryoelectron microscopy and image processing. After image classification, a
homogeneous population of 2,625 particles was obtained and used to generate a threedimensional reconstruction of the CCT:PhLP complex

(Fig. 2-2 A and B). The

reconstruction reveals an asymmetric, bullet-shaped structure as was observed in the twodimensional average image of the side view of the same complex (Fig. 2-1 B). Compared
with the three-dimensional reconstruction of apo-CCT (Fig. 2-2 C), the CCT:PhLP
complex shows important differences, especially in the PhLP-bound CCT ring. One
difference has to do with the mass clearly attributed to PhLP that sits at the entrance of
the cavity and protrudes from it. In contrast to the interaction of CCT with actin (Llorca et
al., 1999), tubulin (Llorca et al., 2000), or its cochaperone, PFD (Martin-Benito et al.,
2002), no part of the PhLP mass penetrates into the folding cavity but simply interacts
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with two opposite sides of the top apical region. The level of resolution of the CCT:PhLP
complex (26 Å) allows visualization of the PhLP mass as a two-domain structure
connected by a small linker. The two domains are clearly asymmetric, the small one
interacting with two CCT subunits and the large one with three subunits (Fig. 2-2 A).

Figure 2-2 Three-dimensional reconstruction of the CCT:PhLP complex by cryoelectron microscopy. (A)
Top view of the CCT:PhLP complex. (B) Side view of the same volume. (C) Side view of the threedimensional reconstruction of apo-CCT (Llorca et al., 2000).

Another difference is a PhLP-induced movement of the apical domains of the CCT
subunits, reducing the diameter of the entrance of the folding cavity from 80 Å to 55 Å
and leaving the entrance almost occluded by the presence of PhLP (Fig. 2-2 A). This
finding confirms the flexibility of the apical domains, which are capable of undergoing
large conformational changes within the functional cycle and of accommodating
substrates of different sizes (Grantham et al., 2000). These large conformational changes
of the apical domains induced by PhLP suggest a high-affinity interaction, consistent with
the 190 nM Kd reported (McLaughlin et al., 2002b). The high binding affinity appears to
derive from a concerted action of the two PhLP domains and all eight CCT subunits,
probably involving multiple contacts. Finally, the reconstruction also confirms the
binding of PhLP to only one of the CCT rings (McLaughlin et al., 2002b) and strongly
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suggests that the movement of the apical domains in the PhLP-bound ring transmits an
allosteric signal through the equatorial domains so that no PhLP molecule is able to bind
to the opposite ring.
Docking Analysis of PhLP into the Three-Dimensional Structure of the CCT:PhLP
Complex.
PhLP belongs to a family of widely expressed regulators of G protein signaling
(Schroder and Lohse, 2000). Although no atomic structure is available for PhLP, there is
a high degree of sequence homology between PhLP and Pdc (41% amino acid identity)
(Miles et al., 1993), another member of the family for which several atomic structures are
available (Gaudet et al., 1996; Gaudet et al., 1999; Loew et al., 1998). This similarity
allowed us to generate an atomic model of PhLP by homology modeling techniques (see
Materials and Methods). The atomic model (Fig. 2-3) lacked the first 50 residues of the
rat PhLP sequence, which are not present in Pdc, and the last 24 residues not defined in
the atomic structures of Pdc. The model naturally shows very similar structural features to
the Pdc atomic structure (Fig. 2-3 B): an unstructured N-terminal domain built up by
three-helices (H1–H3) and a more compact C-terminal domain showing a typical
thioredoxin fold (Gaudet et al., 1996; Martin, 1995), with a core formed by a fivestranded β-sheet (S1–S5) flanked by four α-helices (H4–H7). The two domains are linked
by a flexible loop that connects H3 and S1.
A docking analysis was carried out by fitting the atomic model of PhLP into the
mass of the CCT:PhLP complex attributable to PhLP (Fig. 2-3). The fit is very good only
when the C-terminal domain is assigned to the smaller, more compact of the two PhLP
masses of the reconstructed volume. The N-terminal domain fits well into the larger mass,
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and although there is a portion of the mass that is not filled, this could be attributed to the
50 residues of the N-terminal domain not present in the atomic model (red arrow in Fig.
2-3 B).

Figure 2-3. Docking of the atomic model of PhLP into the three-dimensional reconstruction of the
CCT:PhLP complex. (A) Docking of the atomic model of PhLP into the CCT:PhLP volume. (B and C) Two
enlarged views of the docking of the PhLP atomic model (drawn in tubes) into the CCT:PhLP complex
(depicted in transparent fashion). The red arrow in B indicates a region of the PhLP mass that could be
filled by the 50 residues of the N-terminal sequence of PhLP not present in the PhLP atomic model. The
green regions in the atomic model of PhLP are those suggested by the docking analysis to be involved in
CCT binding.

An analysis of the docking results suggests the involvement of several regions of
PhLP in the binding of CCT (Fig. 2-3 B and C). In the N-terminal domain, a large stretch
of amino acids runs parallel to the apical domains of the three CCT subunits that are in
close proximity to PhLP (Fig. 2-3C) and suggests a possible binding interface (Fig. 2-4A).
This region (K109–E135) encompasses part of the long H1–H2 loop, H2, the H2–H3 loop,
and the N-terminal part of H3. In addition, the 50 N-terminal residues not present in the
atomic model could potentially be involved in CCT binding through an interaction with
the third CCT subunit (red arrow in Fig. 2-3 B). In the C-terminal domain, three regions
are likely candidates for interaction with the two CCT subunits (Fig. 2-3 B and C), the
loops between S2 and H5 (E189–G194), H6 and S4 (G223–N231), and S5 and H7 (V249–D258).
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Additionally, part of the last 24 residues of the sequence, not present in the atomic model,
might be placed in the bottom part of the PhLP mass and therefore could also be involved
in CCT binding. In all, the electron microscopy shows clearly that both domains of PhLP
are involved in CCT binding, and the docking of the atomic model of PhLP into the threedimensional reconstruction of the CCT:PhLP complex points to several specific regions
of both N- and C-terminal domains of PhLP as involved in CCT binding.
Biochemical Analysis of the CCT–PhLP Interaction.
To assess the validity of this structural model of the PhLP–CCT interaction, the
binding properties of a set of chimeric proteins were generated in which the PhLP
sequences implicated in CCT binding by the docking analysis were replaced with the
corresponding Pdc sequence. This mapping strategy takes advantage of the fact that
although both proteins are homologous, only PhLP interacts with CCT (McLaughlin et
al., 2002b). A set of two chimeras was generated in which the N-terminal (residues 1–
153) and C-terminal (residues 154–301) domains of PhLP were switched with the
corresponding region of Pdc (Fig. 2-4A). The two chimeras were then assayed for CCT
and Gβγ binding by coimmunoprecipitation and immunoblotting, the latter serving as a
control for the ability of the chimeras to maintain their functional activity and therefore
their native conformation. The results in Fig. 2-4B show that neither chimera binds CCT
yet both are able to bind Gβγ, indicating that both the N- and C-terminal domains of
PhLP are required for CCT binding. The diminished Gβγ binding of PhLP/Pdc(1–153) is
anticipated, given the fact that the N-terminal domain of PhLP contributes more to Gβγ
binding than that of Pdc, and that the C-terminal domain of PhLP contributes less than the
homologous region of Pdc (Savage et al., 2000). These results clearly confirm the
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structural data showing that contacts from both N- and C-terminal domains of PhLP are
required for CCT binding.

Figure 2-4 Both domains of PhLP participate in CCT binding. A sequence alignment of rat Pdc, PhLP1,
PhLP2, and PhLP3 is shown in A. Conserved residues are indicated with gray boxes, and secondary
structural elements for Pdc (12) are indicated above the sequence (H for helix and S for -strand). Shaded
boxes below the structural elements represent regions implicated in CCT binding by the docking analysis.
A vertical arrow at residue 154 marks the loop between the N-and C-terminal domains. The
PhLP/Pdc(154–301) chimera contains the N-terminal domain of PhLP and the C-terminal domain of Pdc
and vice versa for the PhLP/Pdc(1–153) chimera. In B, the binding of these proteins to CCT or Gβγ was
determined by immunoprecipitation of the PhLP chimeras and immunoblotting for CCTα and Gβ as
described in Materials and Methods. Immunoblots show representative data from three separate
experiments. Positions of molecular weight standards are shown on the right.

The next step was to investigate in detail which specific regions of PhLP are
involved in CCT binding, using the information provided by the docking analysis.
Several PhLP/Pdc chimeric proteins were generated in both N- and C-terminal domains
of PhLP and were also assayed for CCT and Gβγ binding (Figs. 2-5 and 2-6).
In the N-terminal domain, six PhLP/Pdc chimeric proteins were designed to cover
most of the secondary structural elements of this domain (Fig. 2-5 A): PhLP/Pdc(60–73),
in which the putative H1 of PhLP had been switched to the corresponding Pdc sequence;
PhLP/Pdc(76–117) and PhLP/Pdc(95–115), covering all or only the C-terminal half of the
H1–H2 loop respectively; PhLP/Pdc(116–132), encompassing the last few residues of the
H1–H2 loop, H2, and the H2–H3 loop; PhLP/Pdc(130–136), covering the H2–H3 loop
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Figure 2-5 Binding of PhLP/Pdc chimeras within the N-terminal domain to CCT. Chimeras of PhLP within
the N-terminal domain were made by inserting Pdc sequence as shown in A. The numbers indicate the
residues of PhLP that were replaced with the corresponding Pdc residues and conserved residues within the
replacements are located in gray boxes. Binding of these PhLP chimeras to CCT or Gβγ was measured as in
Fig. 2-4. (B) Representative immunoblots for CCT and Gβ, as well as a graphical representation of the CCT
binding data normalized to wild-type PhLP. Bars represent the mean ± standard error from seven separate
experiments. No PhLP was added to the blank sample. In the CCTα immunoblot the standard lane contains
700 ng of purified CCT which corresponds to 90 ng of CCTα. In the Gβ immunoblot the standard lane
contains 25 ng of Gβγ which corresponds to 21 ng of Gβ.

and the three N-terminal residues of H3; and finally, PhLP/Pdc(138–154), encompassing
H3. The CCT binding assay with the PhLP/Pdc(60–73) chimera showed no decrease with
respect to wild-type PhLP (Fig. 2-5 B), consistent with the docking analysis showing no
interaction of H1 with CCT. Binding assays with chimeras PhLP/Pdc(76–117),
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PhLP/Pdc(95–115), and PhLP/Pdc(116–132) revealed a small decrease in the interaction
with the chaperonin (20–30%), indicating that the H1–H2 loop, H2, and the N-terminal
part of the H2–H3 loop individually make only minor contributions to chaperonin
binding. The CCT binding assays with chimeras PhLP/Pdc(130–136) and PhLP/Pdc(138–
154) showed a complete suppression of chaperonin binding. The combined information
obtained from chimeras PhLP/Pdc(116–132), PhLP/Pdc(130–136), and PhLP/Pdc(138–
154) points to H3 and the C-terminal part of the H2–H3 loop as critical for CCT binding
(Fig. 2-5). According to the docking analysis, the H2–H3 loop and the N-terminal part of
H3 make contact with CCT. In the PhLP/Pdc(130–136) chimera, three nonconservative
changes, L131K, E135G, and F136G, abolish CCT binding (Fig. 2-5), suggesting that the
stretch of negative charge D132DEE surrounded by hydrophobic residues is required for
CCT binding. Furthermore, in the PhLP/Pdc(138–154) chimera, H3 residues Q138Q that
are on the same side of H3 as E134E are replaced with R and K, respectively, increasing
the positive charge in this face of H3 (Fig. 2-5). Interestingly, the negatively charged
character of this region is conserved in other PhLP members like PhLP2 and PhLP3 (Fig.
2-4 A), which are also believed to interact with CCT (Aloy et al., 2004; Lacefield and
Solomon, 2003). Indeed, replacement of the D132DEE stretch with alanines in human
PhLP abolishes its CCT binding ability (data not shown). Thus, it appears that the
negatively charged stretch in the H2–H3 loop and at the N terminus of H3 is critical for
CCT binding.
In the C-terminal domain, five chimeras were generated based on the information
extracted from the docking analysis (Fig. 2-6 A). They were PhLP/Pdc(P193R), in which
only a single mutation was necessary to generate the Pdc sequence for the S2–H5 loop;
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PhLP/Pdc(223–234), encompassing the H6–S4 loop; PhLP/Pdc(249–260), encompassing
the S5–H7 loop; and PhLP/Pdc(223–234/249–260), a double-loop chimera switching both
of these two later loops. A fifth chimera, PhLP/Pdc(277–301), covered the last 24
residues of the PhLP sequence, a region whose structure was not predicted by the
homology modeling experiment but which could be potentially involved in chaperonin
binding. The CCT binding assays (Fig. 2-6 B) revealed a 60% decrease in chaperonin
binding for PhLP/Pdc(P193R) compared with wild-type PhLP, suggesting that residue
P193 is involved in the interaction with CCT, probably through the maintenance of a
certain local conformation. Other binding assays showed a small 25% increase in binding
with PhLP/Pdc(223–234) and a large 80% decrease in binding with chimera
PhLP/Pdc(249–260). A similar 80% decrease was observed for the double-loop chimera
PhLP/Pdc(223–234/249–260). These results indicate that the H6–S4 loop is not involved
in CCT interaction, whereas the S5–H7 loop has an important role in chaperonin binding.
In the PhLP/Pdc(249–260) chimera, there is only one nonconservative substitution
(R250S; Fig. 2-6 A), suggesting that the positive charge at R250 plays a role in CCT
binding. Replacement of the last 24 residues of the C-terminal domain of PhLP with
chimera PhLP/Pdc(277–301) generated a significant 50% decrease in CCT binding,
suggesting that this region is also involved in the interaction with the chaperonin.
These biochemical data are generally consistent with the structural model proposed
from the docking analysis, confirming most of the suggested contacts and clearly showing
that PhLP interacts with CCT through specific regions in both N- and C-terminal
domains. In all, the CCT binding experiments shown here suggest that apart from the
stringent binding site in the region encompassing part of the H2–H3 loop and H3, PhLP
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interacts with CCT through the concerted interaction of several regions of both N- and Cterminal domains, similar to what has been described for actin and tubulin (Llorca et al.,
2000; Llorca et al., 1999).

Figure 2-6 Binding of PhLP/Pdc chimeras within the C-terminal domain to CCT. Chimeras of PhLP within
the C-terminal domain were made by inserting Pdc sequence in the loops between the predicted secondary
structural elements as shown in A. The numbers indicate the residues of PhLP that were replaced with the
corresponding Pdc residues and conserved residues within the replacements are located in gray boxes.
Binding of these PhLP chimeras to CCT or Gβγ was measured as in Fig. 2-4. (B) Representative
immunoblots for CCTα and Gβ, as well as a graphical representation of the CCTα binding data normalized
to wild-type PhLP. Bars represent the mean ± standard error from six separate experiments. The lanes
contain the same amounts of protein as in Fig. 2-5.
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As mentioned earlier, the CCT:PhLP structure displays an interesting similarity to
that of the CCT:PFD complex (Martin-Benito et al., 2002) in that PhLP sits above the
CCT folding cavity, contacting the apical domains of the CCT subunits and occluding the
entrance into the cavity. The function of the cochaperone PFD is to assist in the folding of
actin and tubulin by binding to their nascent polypeptide chains and delivering them to
CCT for folding into their native structures (Martin-Benito et al., 2002). Several lines of
evidence suggest a similar role of PhLP with regard to Gβγ folding and/or assembly.
First, genetic deletion of PhLP in Dictyostelium discoideum blocked G protein signaling
and membrane localization of the Gβγ complex (Blaauw et al., 2003). According to these
authors, PhLP could be involved in facilitating the correct folding of Gβ or its assembly
into the Gβγ complex. Second, the need of chaperones for the correct folding of WD40
proteins like Gβ has been already demonstrated (Clapham and Neer, 1997; GarciaHiguera et al., 1998). Interestingly, the interaction of some of these WD40 proteins with
CCT has also been described, and a folding role of CCT has been demonstrated for some
of them (Camasses et al., 2003; Siegers et al., 2003). In fact, CCT seems to interact with
at least 17% of the yeast WD40 proteins including Ste4, the yeast Gβ subunit (Valpuesta
et al., 2002). Third, a proteomic analysis of the protein complexes in yeast revealed an
interaction between CCT, yeast PhLP2, and VID27, a Gβ protein homologue (Aloy et al.,
2004). Fourth, a recent genetic study reveals that the cochaperoning role of PhLP with
respect to CCT could be extended to the folding of β–tubulin (Lacefield and Solomon,
2003). In light of these data, it is tempting to suggest that PhLP acts as a cochaperone in
concert with CCT to catalyze the folding of Gβ proteins and/or the assembly of the Gβγ
complexes.

34

This work was completed in collaboration with Dr. Jose Valpuesta’s group from
Centro Nacional de Biotecnologia in Spain. Jaime Martin-Benito and Sara Bertrand
studied the cryo-EM structure of PhLP:CCT complex, including the two-dimensional
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CHAPTER 3

PhLP and CCT act as co-chaperones in G protein βγ dimer formation

Summary

PhLP is known to be a binding partner and regulator of the G protein βγ subunit
dimer. PhLP also forms a high affinity complex with CCT. However, the physiological
role of PhLP is still an enigma. In the present study, the cellular expression of PhLP was
blocked using RNA interference. Expression of Gβγ and the kinetics of Gβγ assembly
were studied in these PhLP-deficient cells using immunoprecipitation and in vivo pulsechase experiments. Depletion of PhLP resulted in inhibition of Gβγ expression and G
protein signaling and also severely impaired Gβγ assembly. Phosphorylation of PhLP at
serines 18–20 by protein kinase CK2 was required for Gβγ dimer formation, while a highaffinity interaction of PhLP with CCT appeared unnecessary. Interestingly, Gβ was found
to interact with CCT by co-immunoprecipitation and PhLP over-expression increased the
binding of Gβ to CCT. These results suggest that PhLP and CCT act as co-chaperones in
the folding and assembly of the Gβγ dimer by forming a ternary PhLP-Gβ-CCT complex
that is a necessary intermediate in the assembly process.
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Introduction
PhLP was discovered over a decade ago as an ethanol responsive gene in cultured
neural cells (Miles et al., 1993).

It displays 41% identity and 65% homology to

phosducin (Miles et al., 1993) and it binds the Gβγ dimer with high affinity similar to
phosducin (Thibault et al. 1997).

However, the physiological significance of the

interaction of PhLP with Gβγ has proved difficult to determine. Two contradictory
opinions have been formulated from a number of biochemical and genetic studies. One
set of data suggests that PhLP is a negative regulator of G protein signaling by
sequestering Gβγ from its interactions with cell membranes, Gα subunits and G protein
effectors (McLaughlin et al., 2002a; Schroder and Lohse, 2000; Thibault et al., 1997).
The second opinion suggests that PhLP is a positive regulator of G protein signaling
while the underlying mechanism has not been solved. This opinion is based on several
observations.

First, blocking PhLP expression in the mouse brain by antisense

oligonucleotide treatment prolonged the duration of opiate desensitization, contradictory
to the putative role of PhLP as a negative regulator (Garzon et al., 2002). Second, this
notion is also supported by the results of deletion of the orthologous PhLP genes in lower
eukaryotes. Disruption of the BDM-1 gene in the Cryphonectria parasitica (Kasahara et
al., 2000) and the phlp1 gene in Dictyostelium (Blaauw et al., 2003) resulted in inhibition
of G protein expression and G protein signaling, similar to a Gβ-null phenotype.
PhLP is a promising potential regulator for CCT since it interacts with CCT in its
native form. Structural studies of the PhLP:CCT complex in the previous chapter implied
that PhLP has a similar role as prefoldin (PFD), which is a co-chaperonin assisting the
folding of actin by binding to the nascent actin polypeptide chains co-translationally and
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delivering them to CCT for folding into their native structures (Martin-Benito et al.,
2002). Some lines of evidence indirectly support this hypothesis. In Dictyostelium,
inhibition of G protein signaling by disruption of phlp1 resulted in mislocalization of Gβ
and Gγ in the cytosol instead of on the plasma membrane (Blaauw et al., 2003),
indicating that PhLP may be involved in Gβ folding and/or Gβγ assembly. In addition,
indirect genetic evidence suggests that Plp1, a member of Pdc-III subgroup in yeast,
plays a role in the folding and assembly of the nascent β-tubulin polypeptide chain into
the tubulin dimer (Lacefield and Solomon, 2003). However, there is currently no direct
evidence proving that PhLP assists CCT in folding its substrates. Moreover, PhLP is not a
co-chaperone in actin folding because over-expression of PhLP competitively inhibits
actin folding by CCT (McLaughlin et al., 2002b).
CCT assists the folding of numerous cellular proteins, including some WD 40
protein family members (Camasses et al., 2003; Siegers et al., 2003) with β-propeller
structures similar to Gβ. In addition, the yeast Gβ subunit STE4 has been reported to
interact with CCT (Ho et al., 2002). In the present study, we studied the effects of
siRNA-mediated cellular depletion of PhLP on G protein signaling, Gβγ expression, Gβ
localization and Gβγ dimer formation. Similarly, we also evaluated the effect of PhLP
variants lacking CK2 phosphorylation sites or with reduced Gβγ or CCT binding. We
also show that Gβ binds CCT during the Gβγ assembly process and that PhLP enhances
the interaction of Gβ with CCT. These results suggest that PhLP and CCT act as cochaperones in the assembly of Gβγ by forming a ternary PhLP-Gβ-CCT complex.
Materials and methods
Cell culture - HeLa S3 and HEK-293 cells were cultured in DMEM/F-12 (50/50 mix)
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growth media with L-glutamine and 15mM HEPES, supplemented with 10% fetal bovine
serum (HyClone). The cells were subcultured regularly in order to maintain active
growth, but were not used beyond 15 passages.
RNA interference - siRNAs were chemically synthesized to target nucleotides 608–628
of human lamin A/C and nucleotides 152–172 and 345–365 of human PhLP. The PhLP
siRNAs were designated PhLP-A and PhLP-B, respectively. The siRNA transfections
were carried out as described previously (Elbashir et al., 2001). Briefly, HeLa S3 or
HEK-293 cells were cultured in 24-well plates to 50–70% confluency. The cells were
then transfected with siRNA at final concentration of 100 nM using Oligofectamine
(Invitrogen). After 96 h, the cells were either harvested in 2% SDS for expression studies
or used in subsequent assays. Protein levels were determined by immunoblotting as
described previously (McLaughlin et al., 2002b). Briefly, cell lysates containing equal
amounts of total protein (3–7 mg) were resolved by SDS–PAGE, transferred to
nitrocellulose and immunoblotted with polyclonal antibodies to PhLP (Thulin et al.,
1999) or Gβ (Lukov et al., 2004), or a monoclonal antibody to lamin A/C (Santa Cruz
Biotechnology).
In vivo Ca2+ Measurement - HeLa S3 cells were treated for 48 h with siRNA and then
subcultured into clear-bottomed, black-sided 96-well plates and allowed to recover for 24
h. The cells were then washed and serum starved in 100 ml of serum-free media for 18 h.
After the starvation, 100 ml of Calcium Assay Plus Dye (Molecular Devices) with 1mM
Probenicide were added to the wells. At time zero, the cells were stimulated with 50nM
histamine and intracellular Ca2+ levels were measured using a FlexStation plate reader
(Molecular Devices) by excitation at 480 nm and detection at 525 nm. Data were
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normalized to the baseline values before histamine treatment.
Preparation of cDNA constructs
Green fluorescent protein (GFP) was attached to the N terminus of human Gβ1 by
standard recombinant techniques. Briefly, the full open reading frame of GFP was
amplified using appropriate primers containing HindIII and BamHI restriction sites at the
5’ and 3’ ends, respectively. This PCR product was then digested with HindIII and
BamHI and ligated at corresponding sites in Gβ1 in pcDNA3.1 vector (UMR cDNA
Resource Center). Wild-type human PhLP with 3’ c-myc and His6 epitope tags was
constructed in pcDNA3.1/myc-His B vector as described (Carter et al., 2004). The PhLP
Δ1–75 deletion variant was prepared by PCR amplification of the nucleotides
corresponding to amino acids 76–301 and insertion in pcDNA3.1/myc-His B. A starting
ATG sequence was placed in front of the PhLP fragment to ensure proper expression of
the variant. The PhLP 132–135A variant was prepared by substituting D132DEE for
alanine codons, thereby creating a unique SacII restriction site. Two PhLP fragments
were amplified using the T7 forward primer from the vector with a PhLP reverse primer
(50-CAA GCC GCC GCG GCA TTT CTG CAG CAG TAC CGG AAG-30) containing
the SacII site (CCGCGG) and a PhLP forward primer (50-AAA TGC CGC GGC GGC
TTG GTC CTC ATT CAT TAT GGC-30) containing the SacII site with a BGH reverse
primer from the vector. The fragments were digested with SacII, gel purified and ligated.
The product was amplified using T7 forward and BGH reverse primers and inserted in
pcDNA3.1/myc-His B. The PhLP/Pdc 76–94 chimera was prepared in pcDNA3.1/mycHis B using the same strategy as described in Chapter 2. The CK2 site variant of PhLP
(PhLP S18–20A) in which S18SS were substituted for alanine codons was constructed in
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pcDNA3.1/myc-His B using the same method as with PhLP 132–135A. All constructs
were inserted into the vector at the EcoRI and XbaI sites. The pcDNA3.1 vectors
containing N-terminally HA-tagged Gγ2, untagged Gβ1, N-terminally Flag-tagged Gβ1 or
Gαi3 were obtained from the UMR cDNA Resource Center.
Transient transfections HEK-293 cells were siRNA treated and then transfected 24 h
later with 1.0 µg each of HA-Gγ2 and Gβ1 in the pcDNA3.1 vector using Lipofectamine
Plus Reagent according to the manufacturer’s protocol (Invitrogen). The cells were used
in subsequent applications 72 h later. For coexpression experiments not involving siRNA
treatment, HEK-293 cells were plated in 24-well plates so that they were 70–80%
confluent the next day. The cells were then transfected with 0.2 µg of either wild-type
PhLP-myc, one of the PhLP-myc variants or the empty vector as a control along with 0.2
µg each of HA-Gγ2 and Gβ1.
Immunocytochemistry and fluorescence microscopy HEK-293 cells were seeded onto
glass cover slips and siRNA treated as previously described. These cells on glass cover
slips were transfected 24 hours later with 1 µg of GFP-Gβ1 in pcDNA3.1 vector. For coexpression experiments HEK-293 cells were plated onto coverslips so that they were 70–
80% confluent the next day and transfected with 1µg of GFP-Gβ1 in pcDNA3.1 vector
along with 1 µg of PhLP-myc in pcDNA3.1 vector. Two days after transfection, adherent
cells on coverslips were rinsed with 2 ml/well of phosphate-buffered saline (PBS) and
fixed with 1 ml/well of 4% paraformaldehyde (PFA) in PBS at 4oC overnight. The
coverslips were then washed in PBS three times for 5 min. GFP was excited with the 488
nm argon ion laser and visualized under a Fluoview300 confocal fluorescence
microscope (Olympus) with an oil immersion lens (magnification 60X).
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Radiolabel pulse–chase assay Transfected HEK-293 cells in 24-well plates were washed
and incubated for 1 h in 500 µl of methionine-free DMEM media (Mediatech Inc.)
supplemented with 4 mM L-glutamine (Sigma), 0.063 g/l L-cystine dihydrochloride
(USB) and 10% dialyzed fetal bovine serum (Invitrogen). The media were discarded and
200 µl of new media supplemented with 200 mCi/ml radiolabeled L-[35S]methionine
(Amersham Biosciences) was added. The cells were then incubated at 23oC for 10 min to
incorporate the [35S]methionine into newly synthesized proteins. After this pulse phase,
the cells were washed and incubated at 23oC for the time periods indicated in 1ml of
media supplemented with 4 mM nonradiaolabeled L-methionine (Sigma) to stop the
[35S]methionine incorporation. Following this chase period, the cells were harvested for
immunoprecipitation experiments. When multiple immunoprecipitations were carried out
from the same cell extract (Fig. 3-6), a six-well plate format was used. The cells were
washed and incubated in 2 ml of the methionine-free media, incubated for 30 min in 1 ml
of the L-[35S]methionine media, and then harvested for immunoprecipitation
experiments.
Immunoprecipitation experiments Transfected HEK-293 cells were washed with
phosphate-buffered saline (PBS) (Fisher) and solubilized in immunoprecipitation buffer
(PBS, pH 7.4, 2% IGEPAL (Sigma), 0.6mM PMSF, 1 mg/ml leupeptin, pepstatin and
aprotinin). The lysates were passed 10 times through a 25G needle and centrifuged at
maximum speed for 10 min at 4oC in an Eppendorf microfuge. The clarified lysates were
incubated with 2 µg of anti-c-myc (clone 9E10, BioMol), anti-HA (clone 3F10, Roche)
or anti-Flag (clone M2, Sigma) antibodies and 25 ml of a 50% slurry of Protein A/G Plus
agarose (Santa Cruz Biotechnology) as described previously. The precipitate was
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solubilized in SDS sample buffer and resolved on 10% Tris–Glycine–SDS or 16.5%
Tris–Tricine–SDS gels. The gels were either dried for radioactivity measurements, or
they were immunoblotted using the Gβ1, c-myc or HA antibodies described above, or a
rabbit polyclonal anti-CCTε antibody (Martin-Benito et al., 2004). Immunoblots were
developed with the ECL Plus chemiluminescence reagent (Amersham). Gels and
immunoblots were visualized with a Storm 860 phosphorimager, and the band intensities
were quantified using Image Quant software (GE Healthcare). The molar ratios were
determined by normalizing the band intensities to the number of methionine residues
found in PhLP, Gβ and Gγ and then calculating the ratios as indicated. The rate data for
Gβγ assembly were fit to a first-order rate equation with background correction to
determine the rate constant (k), and the t1/2 for assembly was calculated as follows: t1/2 =
ln 2/k. For CCT co-immunoprecipitation experiment, procedures are identical as
described above except that 2 µg of CCT-ε (Serotec Inc.) was added to each sample of
HEK-293 cells lysates.
Northern blotting The effects of siRNA treatment or PhLP variant over-expression on
endogenous Gβ or overexpressed Gβ and Gγ mRNA levels were determined by Northern
blotting. Total RNA was isolated from cells in a six-well plate using the RNAqueous kit
(Ambion). RNA was loaded (15 µg/well) and separated on 1.0–1.5% agarose/8.0%
formaldehyde gels. Gels were transferred to a Hybond-N+ membrane (Amersham) by
capillary action for 1 h in 0.01M NaOH, 3M NaCl for the endogenous Gβ mRNA or for
16 h in 10X SSC buffer (1.5M NaCl, 0.15M sodium citrate, pH 7.0) for the
overexpressed Gβ and Gγ mRNAs. The membranes were prehybrized with ExpressHyb
hybridization buffer (Clonetech) for 1 h at 65oC. A radiolabeled probe was prepared
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using a PCR amplicon from 500 bp of the 30-untranslated region of the wild-type Gβ1
gene as a template or from the entire coding region of the overexpressed Gβ1 and Gγ2
cDNAs. The probe was radiolabeled by the random hexamer method using the Prime-aGene labeling system (Promega). Membranes were hybridized with the probe in
ExpressHyb buffer for 1 h at 65oC and washed twice for 15 min at 37oC. Radioactivity
was visualized and quantified using the phosphorimager. Membranes were then stripped
by washing twice in 0.1% SDS for 15 min at 95oC and reprobed for glyceraldehydes 3phosphate dehydrogenase (GAPDH). The Gβ and Gγ band intensities were normalized to
the GAPDH band intensity.
Results
Cellular depletion of PhLP inhibits Gβ expression and G protein signaling
siRNA is a powerful tool to specifically knock-down the cellular levels of the
mRNA and protein product of the targeted gene (Kaykas and Moon, 2004). To
investigate the role of PhLP in G protein signaling, two siRNAs targeting different
sequences of PhLP, PhLP-A and PhLP-B, were designed and tested for their ability to
block cellular expression of PhLP. As a negative control, siRNA to lamin A/C was
prepared and tested as well. Lamin A/C is a traditional and convenient control for
siRNAs experiments because this nuclear membrane protein is ubiquitously expressed in
nearly all somatic cells and knockdown of its mRNA does not affect cell viability. As
shown in Figure 3-1A, transfection with PhLP-A siRNA suppressed the expression of
PhLP moderately by 50% compared with mock-transfected cells or cells transfected with
lamin A/C siRNA. However, PhLP-B siRNA was able to reduce PhLP more efficiently
by up to 90%. Both siRNAs are specifically against PhLP since they have no effect on
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the expression of lamin A/C.
The effects of siRNA-mediated PhLP knockdown on Gβ expression and G protein
signaling were also determined. Gβ1 expression in the PhLP siRNA-treated cells was
measured by immunoblotting since Gβ1 is the most widely and abundantly expressed Gβ
subunit. PhLP-B siRNA treatment resulted in a 40% reduction in Gβ1 protein level while
there was no change in Gβ1 expression in PhLP-A siRNA-treated cells when compared to
mock-transfected or lamin A/C siRNA-transfected controls cells (Fig. 3-1 A).
The reduction in Gβ1 expression caused by siRNA-mediated depletion of PhLP
would be expected to inhibit G protein signaling. This possibility was tested by
measuring the response of HeLa cells to histamine. The H1 histamine receptor couples to
Gq/11 G protein sub-family to activate PLC-β and catalyze the production of IP3 which in
turn results in an increase of intracellular Ca2+ concentration (Bootman et al., 1997).
Thus, the increase in cytosolic Ca2+ upon histamine stimulation was measured in the
PhLP-depleted HeLa cells. PhLP-B siRNA treatment inhibited Ca2+ accumulation by
60% when compared with control cells either mock-transfected or lamin A/C siRNA transfected, while PhLP-A siRNA treatment resulted in a more modest 20% decrease.
These decreases in cytosolic Ca2+ accumulation correspond with the decrease Gβ
expression upon PhLP depletion and support the idea that PhLP is a positive mediator of
G protein signaling.
The observed decreases in Gβ1 expression upon PhLP depletion could be caused by
the effects of PhLP at any stage of Gβ1 expression, such as transcription, mRNA stability,
translation and degradation. To test whether PhLP regulates the transcription or stability
of the Gβ1 mRNA, the effect of PhLP depletion on Gβ1 mRNA levels was measured
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using Northern blotting. As shown in Figure 3-1C, Gβ1 mRNA level in Hela cells treated
with both PhLP-A and -B siRNAs were the same as control cells, indicating that PhLP
does not play a role in Gβ1 transcription or mRNA stability. This result points to a
function of PhLP in Gβ translational or post-translational processing.
Figure 3-1 siRNA-mediated depletion
of PhLP inhibits Gβ expression and G
protein signaling. (A) HeLa S3 cells
were treated with the indicated
siRNAs and then assayed after 96 h.
Protein expression of PhLP, Gβl and
lamin A/C were determined by
immunoblotting. PhLP and Gβ1 band
intensities were quantified and
expressed as a percentage of the lamin
A/C sample. Bars and symbols in each
panel represent the average+s.e. from
three separate experiments. Statistical
significance relative to the lamin A/C
control was determined by a paired ttest (*P<0.01). (B) Changes in
intracellular Ca2+ in living cells were
determined by measuring fluorescence
from a Ca2+-sensitive dye using a
FlexStation plate reader. Histamine
(50 nM) was added at time zero and
measurements were taken at the times
indicated. Fluorescence data were
normalized to the signal prior to
histamine addition. (C) Levels of Gβ1
and GAPDH mRNA were determined
by Northern blotting. Band intensities
were quantified, normalized to that of
GAPDH and expressed as a
percentage of the lamin A/C sample.
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Expression of GFP-Gβ1 is severely inhibited in HEK-293 cells depleted of PhLP

Figure 3-2 Confocal images of GFP-Gβl in HEK-293 cells treated with PhLP siRNA or over-expressing
wild-type PhLP. HEK-293 cells were treated with the indicated siRNAs (C-E) or mock transfected (A) and
then transiently transfected with GFP-Gβl . Alternatively, cells were co-transfected with PhLP along with
GFP-Gβ1 and Gγ2 (B). Cells were then fixed and visualized using a 485/20 excitation and 530/25 emission
filter set.

Normally Gβγ is localized at the plasma membrane in wild-type cells. However,
phlp-1 deletion in Dictyostelium cells appears to result in mislocalization of GFP-Gβ and
GFP-Gγ in the cytosol, which could explain the inhibition of G protein signaling in these
cells (Blaauw et al., 2003). In order to examine the effects of PhLP on subcellular
localization of Gβ in mammalian cells, we over-expressed GFP-Gβ1 and Gγ2 in HEK-293
cells in which PhLP had been either siRNA-depleted or over-expressed. Surprisingly,
confocal fluorescence microscopy images of these cells showed a drastic reduction of
GFP-Gβ expression in PhLP-B siRNA-treated cells and to a lesser extent in PhLP-A
siRNA treated cells when compared to mock-transfected or lamin A/C siRNA-treated
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control cells (Fig. 3-2). In contrast, over-expression of PhLP significantly enhanced GFPGβ expression. The localization of GFP-Gβ that remained after PhLP siRNA treatment
appeared to be similar to the control cells with most plasma membrane associated and
some cytosolic. These data indicate that PhLP is required for over-expression of Gβ, an
observation that is consistent with the effects of PhLP-depletion on endogenous Gβ
expression (Fig. 3-1A).
PhLP is required for Gβγ dimer assembly
The interaction of PhLP with CCT suggests that PhLP may play a role in the posttranslational folding of nascent polypeptides and their assembly into protein complexes.
With regard to complex assembly, CCT has been shown to participate in the formation of
the von Hippel-Lindau tumor suppressor protein complex with elongins B and C
(Feldman et al., 1999). These observations led to the idea that PhLP might contribute to
Gβγ dimer formation.

A role for PhLP in Gβγ assembly would account for the

immunofluorescence data showing a dramatic decrease in Gβ over-expression upon PhLP
depletion. Thus, the effects of PhLP depletion on formation of the Gβγ dimer were
investigated. HEK-293 cells were pretreated with siRNA and co-transfected 24 hours
later with HA-Gγ2 and Gβ1. The HA-Gγ2 was immunoprecipitated from cell lysates with
an anti-HA antibody, and the immunoprecipitates were immunoblotted for Gβ1 and HAGγ2 to determine the amount of Gβγ complex in the cells. PhLP-A and -B siRNA
inhibited PhLP expression level by 25 and 70% respectively, and brought down Gβγ
expression accordingly by 35 and 75% when compared to lamin A/C controls (Fig. 3-3
A). Both the Gβ and Gγ bands were decreased equally in the immunoprecipitates, so it
could not be determined whether PhLP depletion blocked Gβγ dimer formation or
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whether it blocked other processes in Gβ and Gγ expression. Northern blot analysis was
performed to check whether reduction of PhLP affected Gβ and Gγ mRNA levels. Only
minor differences in Gβ1 and Gγ2 mRNA levels were observed compared to mocktransfected and lamin A/C transfected controls (Fig. 3-3 C). These small fluctuations in
mRNA amounts cannot account for the large decrease in Gβγ expression in PhLP-B
siRNA treated cells (Fig. 3-3A). This observation is consistent with the effects of PhLP
depletion on endogenous Gβ expression shown in Figure 3-1 and further suggests a role
for PhLP in translation or post-translational events in Gβγ expression.
To directly examine the possibility that PhLP participates in Gβγ assembly, the
effects of PhLP depletion on the rate of nascent Gβγ assembly were determined in a
pulse-chase experimental format. HEK-293 cells were pretreated with PhLP siRNA and
transfected with Gβ1 and HA-Gγ2. The cells were then pulsed with [35S]methionine for 10
min and chased for different times as indicated in figure 3-3B.
In lamin A/C treated cells, the amount of nascent Gβ1 associated with HA-Gγ2 in the
immunoprecipitates increased significantly during the chase period. In contrast, there was
almost no increase in nascent Gβ associated with HA-Gγ in the PhLP-B siRNA treated
cells. There was also an ~50% decrease in the amount of HA-Gγ2 synthesized during the
pulse period in PhLP-B siRNA treated cells. To clearly measure the difference in the rate
of Gβγ assembly in PhLP-depleted cells, the Gβ/Gγ ratio was calculated at each time
point during the chase period and was fit to a rate equation. From the fit, the rate
constants and the half-lives for assembly were calculated. PhLP depletion decreased the
rate of Gβγ assembly by 5-fold compared to the lamin A/C control. The half-life for Gβγ
assembly in the lamin A/C control was ~60 min., while the half-life in PhLP-B siRNA
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treated cells was ~300 min. This result shows that PhLP is indispensable for the Gβγ
assembly.

C

Figure 3-3 siRNA-mediated depletion of PhLP inhibits Gβγ dimer assembly. (A) HEK-293 cells were
treated with the indicated siRNA and transiently transfected with Gβl and HA-Gγ2 and then assayed after
96 h. Levels of overexpressed Gβlγ2 dimer were determined by immunoprecipitating HA-Gγ2 and
immunoblotting for Gβl and HA-Gγ2. The effect of siRNA treatment on PhLP expression in HEK-293 cells
was determined by immunoblotting whole-cell extracts for PhLP. Band intensities were quantified and
expressed as a percentage of the lamin A/C sample. Bars and symbols in each panel represent the
average±s.e. from three or four separate experiments (*P<0.01). (B) The rate of nascent Gβlγ2 dimer
formation was determined using a radiolabel pulse−chase assay. Cells were pulsed for 10 min with
[35S]methionine followed by a chase with unlabeled methionine. Times indicate the sum of the pulse and
chase periods. After the chase, Gβlγ2 dimers were immunoprecipitated with an antibody to HA-Gγ2.The
dimers were resolved by Tris−Tricine−SDS−PAGE and radioactive protein bands were detected using a
phosphorimager. Band intensities were quantified and molar ratios of Gβl to Gγ2 were calculated. Lines
represent a nonlinear least-squares fit of the data to a first-order rate equation. Values for t1/2 are shown
next to the graph. (C) Levels of Gβ1, Gγ2 and GAPDH mRNA were determined by Northern blotting. Band
intensities were quantified, normalized to that of GAPDH and expressed as a percentage of the lamin A/C
sample.
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PhLP phosphorylation at serines 18–20 is required for Gβγ dimer assembly
PhLP has been reported to be constitutively phosphorylated by protein kinase CK2
at serines 18-20 in mammalian cell lines (Humrich et al., 2003). CK2 phosphorylation
does not change PhLP binding affinity for Gβγ but increases binding affinity for CCT by
seven-fold (unpublished observations). Over-expression of PhLP S18-20A (a PhLP
variant with serine 18-20 substituted by alanine) and PhLP Δ1-28 (a PhLP truncation
lacking amino acids 1-28) is much more potent than wild-type PhLP in blocking
activation of PLC-β by over-expressed Gβγ (Humrich et al, 2003). These observations
suggest that CK2 phosphorylation of PhLP is involved in the regulation of Gβγ assembly.
To test this possibility, the effects of CK2 phosphorylation of PhLP on the expression and
assembly of Gβγ were measured using the pulse-chase experimental format of Figure 3-3.
Gβ1 and HA-Gγ2 was transfected into HEK-293 cell along with PhLP S18-20A, wildtype PhLP or empty vector as a control. PhLP S18-20A inhibited Gβγ expression
approximately by 70% compared to wild-type PhLP.

Northern blot analysis

demonstrated that Gβ mRNA decreased roughly 20-30% in HEK-293 cell co-transfected
with PhLP S18-20A compared with wild-type PhLP (Fig. 3-4C). This small reduction of
mRNA is not responsible for the 70% decrease of Gβγ protein expression, thus PhLP
S18-20A might inhibit Gβγ assembly. The effect of PhLP S18-20A over-expression on
the rate of Gβγ assembly was determined in a pulse-chase experiment as in Figure 3-3.
The rate of assembly in PhLP S18-20A tranfected cells was 15-fold slower than in wildtype PhLP transfected cells and 4-fold slower than empty vector transfected cells with
half-lives of 184, 12 and 45 min, respectively (Fig. 3-4B). This inhibition of Gβγ
assembly by PhLP S18-20A suggests that phosphorylation of PhLP at serines 18–20 by
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CK2 is required for Gβγ dimer formation.

C

Figure 3-4 PhLP phosphorylation at serines 18–20 is required for Gβγ dimer assembly. (A) HEK-293 cells
were transiently transfected with PhLP-myc, PhLP S18-20A or empty vector as indicated along with Gβ1
and HA-Gγ2 and then assayed after 48 h. Levels of overexpressed Gβlγ2 dimer were determined by
immunoprecipitation as in Figure 3-3A. Bars represent the average s.e. from six separate experiments
(*P<0.01, **P<0.001). (B) The rate of nascent Gβlγ2 dimer formation was determined by a pulse–chase
assay as in Figure 3-3B. Symbols represent the average±s.e. from three separate experiments. (C) Levels of
Gβ1, Gγ2 and GAPDH mRNA were determined by Northern blotting. Band intensities were quantified,
normalized to that of GAPDH and expressed as a percentage of the lamin A/C sample.

Gβ binds CCT and PhLP increases the interaction
A number of observations point to a role for CCT in Gβγ assembly. For example,
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proteomic screens for protein-protein interactions in yeast found that yeast Gβ (Ste4)
interacts with CCT (Ho et al., 2002). Moreover, the structure of the PhLP-CCT complex
suggests that Gβ might sit below PhLP in the CCT folding cavity and form a ternary
PhLP-Gβ-CCT complex that is an intermediate in the assembly process. To test this
possibility, the binding of Gβ to CCT and the effect of PhLP on a putative Gβ-CCT
interaction was measured. HEK-293 cells were transfected with empty vector, Flagtagged Gβ alone, Flag-tagged Gβ along with either myc-tagged PhLP or Gγ2, or all three
together (Gβ, Gγ2, PhLP). After 48 hrs, the cells were lysed and immunoprecipitated
with an antibody to the CCTε subunit. The immunoprecipitates were immunoblotted
with an antibody against the Flag tag. Equal amounts of total cell lysate were also
immunoblotted with the Flag antibody to check the total Gβ expression level.
A

B

Figure 3-5 PhLP increases the binding of Gβ to CCT. HEK-293 cells were transiently transfected with
empty vector, Flag-Gβ1, PhLP-myc and Gγ2 as indicated. After 48 h, cells were extracted and
immunoprecipated with an antibody to CCTε and immunoblotted with an anti-Flag antibody. The blots
were developed by enhanced chemiluminescence and visualized with a phosphorimager (A). Equal
amounts of total cell lystate were immunoblotted with the anti-Flag antibody as a gel loading control (B).
Blots are representative of similar data from three experiments.

As shown in Figure 3-5, Flag-tagged Gβ co-immunoprecipitated with CCT in all
samples and PhLP co-expression increased the amount of Flag-tagged Gβ in the CCT
immunoprecipitates. In contrast, Gγ2 co-expression decreased the amount of Gβ1 bound
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to CCT in both the presence and absence of PhLP. These results show that Gβ does bind
CCT and that a PhLP-Gβ-CCT ternary complex may form prior to the binding of Gγ to
Gβ. Once Gγ associates, the Gβγ complex appears to dissociate from CCT as it binds to
Gα and is trafficked to the plasma membrane.
High-affinity binding of PhLP to Gβγ but not to CCT is necessary for Gβγ assembly
The binding interactions of PhLP, Gβ and CCT indicate that CCT and PhLP might
work together to fold and assemble the Gβγ dimer. To investigate the roles of PhLP
binding to CCT and PhLP binding to Gβ in Gβγ assembly, PhLP variants deficient in
CCT or Gβγ binding were prepared and their effects on Gβγ expression and assembly
were measured. The PhLP variant deficient in CCT binding was constructed based on
the PhLP:CCT structure reported in Chapter 2. That work suggested that a negatively
charged sequence of amino acids between Helix 2 and 3 of PhLP (D132DEE) was
important in the PhLP-CCT interaction. As a result, a PhLP variant in which these four
residues were replaced by alanine was prepared. This PhLP 132-135A variant bound
CCT much less than wild-type PhLP in co-immunoprecipitation experiments, yet it
showed normal Gβγ binding (Fig. 3-6A) PhLP variants that were deficient in Gβγ
binding were also prepared. The first variant was a truncation of the first 75 amino acids
of PhLP (PhLP Δ1-75), while the second variant was a PhLP/Pdc chimeric protein in
which PhLP residues 76-94 replaced with the corresponding region of Pdc (PhLP/Pdc 7694). PhLP Δ1-75 lacks Helix 1 of PhLP which contributes significantly to the Gβγ
interaction, while PhLP/Pdc 76-94 was in a region of PhLP not known previously to
participate in Gβγ binding. PhLP Δ1-75 bound Gβγ much less that wild-type, while

54

PhLP/Pdc 76-94 showed moderate Gβγ binding, less than wild-type but more that PhLP
Δ1-75 (Fig. 3-6A). Both of these variants bound CCT as well as wild-type (Fig. 3-6A).

D

Figure 3-6 Interaction of PhLP with Gβγ but not with CCT is necessary for Gβγ dimer assembly. (A)
HEK-293 cells were transiently transfected with PhLP-myc, PhLP 132−135A, PhLP Δ1−75, PhLP/Pdc
76−94, or empty vector as indicated along with Gβ1 and HA-Gγ2 and then assayed after 48 h. The binding
of PhLP variants to Gβγ and CCT was measured by immunoprecipitating with an antibody to the Cterminal myc tag and immunoblotting for PhLP, Gβ or CCTε. Blots are representative of similar data from
three experiments. (B) Levels of overexpressed Gβlγ2 dimer were determined by immunoprecipitation as in
Figure 3-2A. Bars represent the average±s.e.from three separate experiments (*P<0.01, **P<0.001). (C) The
rate of nascent Gβlγ2 dimer formation was determined by a pulse−chase assay as in Figure 3-3B. Symbols
represent the average±s.e.from three separate experiments. (D) Levels of Gβ1, Gγ2 and GAPDH mRNA
were determined by Northern blotting. Band intensities were quantified, normalized to that of GAPDH and
expressed as a percentage of the lamin A/C sample.
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These three PhLP variants were co-transfected with Gβ1 and HA-Gγ2 and their
effect on Gβγ expression was tested as in Figure 3-3. PhLP 132-135A increased Gβγ
expression slightly by ~20% while PhLP Δ1-75 strikingly inhibited Gβγ expression by
90% and PhLP/Pdc 76-94 inhibited Gβγ expression by 50%. The extent of the inhibition
appears to be directly related to the binding affinity of these variants for Gβγ and has no
correlation with their binding affinity for CCT. Northern blot analysis showed no
significant differences in the mRNA levels of Gβ and Gγ compared with wild-type PhLP
or the empty vector control (Fig. 3-6D), indicating that the inhibition of Gβγ expression
in cells co-expressing PhLP Δ1–75 or PhLP/Pdc 76–94 was not caused by changes in
mRNA levels. Gβγ assembly measurements in cells co-expressing these PhLP variants
yielded results that paralleled those of Gβγ expression. The rate of Gβγ assembly in cells
co-expressing PhLP132–135A was as rapid as wild-type PhLP (Fig. 3-6C). In stark
contrast, co-expression of PhLP Δ1–75 dramatically inhibited Gβγ assembly to the point
where it was negligible. PhLP/Pdc 76-94 showed an intermediate result in which Gβγ
assembly was decreased by 4-fold compared to wild-type, but was much greater than that
of PhLPΔ1-75. These results suggest that an interaction of PhLP with Gβγ is vital for
Gβγ dimer formation while high-affinity binding of PhLP to CCT appears unnecessary.
Discussion
PhLP is a co-chaperone for Gβγ assembly
Previous studies of PhLP have resulted in two contradictory views of the
physiological role of PhLP. By virtue of its ability of binding for Gβγ, PhLP was
regarded as a cellular “sink”, sequestering the free Gβγ in the cytosol and blocking Gβγ
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signaling. Thus, PhLP was believed to be a negative regulator of Gβγ signaling, as
supported by several studies (Ford et al., 1998; McLaughlin et al., 2002a). These studies
were generally conducted either in over-expression or reconstitution experiments with
exogenous PhLP added. In these systems, PhLP concentration was higher than under
physiological conditions, thus excess PhLP could bind Gβγ and block Gβγ binding to Gα
and effectors. Recent studies using genetic deletion, however, suggested that PhLP1 in
lower eukaryote is required for Gβγ signaling (Blaauw et al., 2003; Kasahara et al.,
2000). The work presented here, measuring the effects of siRNA-mediated depletion of
PhLP on the expression and assembly of Gβγ argue strongly that PhLP is an essential,
positive regulator of G protein signaling. Northern blot analysis showed that siRNA
targeting of PhLP and over-expression of PhLP variants did not alter the Gβ mRNA
levels, suggesting that the decrease in Gβ expression is a translational or posttranslational event. Kinetic measurements of Gβγ assembly using pulse-chase
experiments revealed that PhLP is an essential chaperone assisting the formation of Gβγ
dimers.
Phosphorylation of PhLP at serines 18–20 by protein kinase CK2 enhances its
binding to CCT and is required for Gβγ dimer formation. It is logical to speculate that
CK2 phosphorylation enables PhLP to recruit CCT since CK2 phosphorylation increases
PhLP binding to CCT. However, a high affinity PhLP-CCT interaction appears
unnecessary since the PhLP132-135A variant lacking of CCT binding is fully capable of
catalyzing Gβγ assembly. The dominant-negative effect PhLP Δ1–75 and PhLP/Pdc 7694 variants with reduced binding affinity for Gβ suggest that they block Gβγ assembly by
displacing endogenous PhLP from other binding partners, such as CCT. The role of
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phosphorylation and how PhLP participates in the assembly process remains unclear.
The role of CCT in Gβγ dimer formation
Gβ has a highly integrated β-propeller structure of 7 blades with each blade
composed of a four-stranded anti-parallel β-sheet (Gaudet et al., 1996). Other WD-40
family members, such as CDC 20, have similar structure as Gβ and require CCT for their
folding (Camasses et al., 2003). In wheat germ lysate, Gβ can be synthesized efficiently
but it cannot dimerize with Gγ. In rabbit reticulocyte lysate, Gβ can be synthesized and
assembled with Gγ, suggesting that Gβ requires a chaperonin or other factors present in
reticulocyte lysate to acquire its assembly-competent conformation (Mende et al., 1995).
In yeast, the yeast Gβ subunit Ste4 has been found to interact with CCT (Ho et al., 2002).
Taken together, these data suggest that Gβ is a folding substrate of CCT. The observation
that Gβ binds CCT in co-immunoprecipitation experiments strongly supported this notion
(Fig. 3-5). PhLP appears to mediate this interaction, since over-expression of PhLP
increased the amount of Gβ bound to CCT. PhLP has been shown to have a high binding
affinity for CCT (McLaughlin et al., 2002b), providing an important link and
rationalization for a role for CCT in PhLP-mediated Gβγ dimer formation. However, the
PhLP 132-135A variant that binds CCT poorly was as effective as wild-type PhLP in
catalyzing Gβγ assembly. How can these disparate observations concerning the role of
CCT in Gβγ assembly be reconciled? The current data do not provide an answer, but
future work will examine the role of CCT in the Gβγ assembly process.
PhLP enhances Gβ and Gγ translation
In cells depleted of PhLP or in cells over-expressing the PhLP S18–20A and
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PhLPΔ1–75 variants, steady-state expression of Gβ and Gγ was significantly reduced as
well as the rate of Gβγ dimer formation. Northern blot analysis has shown this reduction
is not a consequence of inhibited transcription or a decrease in mRNA stability (Figures
3-1C, 3-3C, 3-4C, 3-6D). Perhaps the reduction can be explained by inefficient folding
or compromised Gβγ assembly which results in the release of unassembled Gβ and Gγ
polypeptide chains into the cytosol in a non-native state, eventually causing their
degradation. However, there was no proteolytic degradation of nascent Gβ and Gγ
observed during the 100 min time course of the pulse/chase experiments (Figures 3-3B,
3-4B and 3-6C), suggesting that the defect is in Gβ and Gγ translation. Unassembled Gβ
or Gγ may inhibit further translation of the Gβ and Gγ mRNAs. A similar mechanism of
negative autoregulation of translation initiation mediated by unassembled subunits of
protein complexes has been described in other systems (Choquet et al., 1998; Choquet et
al., 2001).
This research has clarified the physiological role of PhLP in G protein signaling
and has provided deeper insight into the PhLP-mediated Gβγ expression and assembly.
Given the large number of diseases linked to malfunctions in G protein signaling, the
PhLP-Gβγ interface is an attractive target for therapeutic interventions. For example, in
diseases caused by overactive G proteins, especially those linked to Gβγ effectors, small
molecules disrupting the interaction between PhLP and Gβ could be designed and tested
for their therapeutic benefit. In addition, genetic methods such as siRNA targeting of
PhLP expression could also be explored. Furthermore, the requirement for CK2
phosphorylation of PhLP in Gβγ assembly suggests that specific inhibition of PhLP
phosphorylation by CK2 might be another promising therapeutic strategy. Thus, these
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findings appear to have opened up new avenues to pursue in the treatment of G protein
linked diseases.
This work was completed together with Dr. Georgi Lukov. He did all the siRNA
work, the measurements of Gβγ expression by immunoblotting and the pulse-chase
experiments.
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